Agenus Inc. (AGEN) Buy Target $2.80 – Sell Target $3.72

Trade Setup

Buy Target $2.80Sell Target 1 $3.34
Trailing Stop 20%Sell Target 2 $3.72

Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body’s immune system to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, LAG-3, and others